Indefinite Delivery Contract 75D30120D07980
Award Date
4/23/20
Last Date to Order
4/22/21
Federal Agency
CDC Pittsburgh
Awardee
Bioreference Health LLC
Ultimate Awardee
Opko Health, Inc.
NAICS Category
621511 - Medical Laboratories
PSC Category
Q301 - Reference Laboratory Testing
Federal Contract Vehicle
Pricing Type
Firm Fixed Price
Legislative Mandate
Service Contract Inventory
National Interest Action
None
Award Type
Multiple
Primary Consortia Member
Not listed
Similar IDVs
The Centers for Disease Control and Prevention awarded an indefinite delivery contract to Laboratory Corporation of America Holdings to provide surge serology testing services in support of COVID-19 response efforts. The multiple award contract has a potential value of $23.75 million and was awarded on May 7, 2020 to aid the agency through April 22, 2021. Two firm fixed price delivery orders have been issued against the contract to date. Laboratory Corporation will perform testing from its...
The Centers for Disease Control and Prevention awarded a multiple award indefinite delivery contract to Quest Diagnostics Incorporated for surge serology testing services. The contract established a potential value of $23.75 million for Quest Diagnostics to provide COVID-19 antibody testing from its Secaucus, New Jersey laboratory in support of the CDC's pandemic response. A $14 million firm fixed price delivery order to Quest Diagnostics expanded the scope of work. Under the delivery order,...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC) to Corgenix Medical Corporation, a foreign-owned, small disadvantaged business manufacturer of goods. The $23,650,000 contract is for "SURGE SEROLOGY TESTING" services, with a period of performance from April 23, 2020 to April 22, 2021. As an IDC, this contract allows the CDC to issue task orders for serology testing services as needed. The contract does not appear to have any...
This indefinite delivery contract (IDC) was awarded by the Centers for Disease Control and Prevention (CDC), a civilian agency, to Battelle Memorial Institute, a non-profit organization and manufacturer of goods, to provide serology surge testing services. The contract has a ceiling value of $23,750,000 and a period of performance from April 2020 to April 2021. As a multiple award IDC, this vehicle provides the CDC with flexible access to Battelle's scientific and technical capabilities in areas...
The Centers for Disease Control and Prevention (CDC) awarded an Indefinite Delivery/Indefinite Quantity (IDIQ) contract with a $118 million ceiling value to Aegis Sciences Corporation, a for-profit forensic toxicology and healthcare laboratory, to provide "TEST SURGE AND DATA SHARING" support services. Under this IDIQ, the CDC has issued two firm fixed price and time and materials task orders to Aegis. The first is a $2,427,648.50 firm fixed price task order with a period of...
The Centers for Disease Control and Prevention (CDC) awarded a multiple-award Indefinite Delivery Indefinite Quantity (IDIQ) contract titled "Test Surge and Data Sharing" to Quest Diagnostics Incorporated, a provider of diagnostic information services. The $118 million IDIQ contract has a period of performance through September 2029 and allows the CDC to procure clinical laboratory testing and analysis services from Quest Diagnostics on an as-needed basis. The contract does not have...
The Indefinite Delivery Contract is a multiple award issued by the Department of Health and Human Services Centers for Disease Control and Prevention Pittsburgh. It has a potential value of $23,750,000 and was awarded on April 23, 2020 to the University of Washington School of Medicine for SURGE SEROLOGY TESTING. No set-aside was used. Orders may be placed through April 22, 2021. The purpose of the contract is to provide surge serology testing in support of the Centers for Disease Control and...
The Centers for Disease Control and Prevention (CDC), part of the Department of Health and Human Services, awarded a $5 million indefinite delivery contract to Signify Health LLC, doing business as Censeohealth, to provide COVID-19 testing services for nursing home residents and staff in Dallas, Texas. Under this contract, Signify Health has received multiple firm fixed-price delivery orders totaling over $2.5 million since May 2020 to supply COVID-19 tests. This contract supports the CDC's...
This single award indefinite delivery contract from the Department of Health and Human Services' Food and Drug Administration to Laboratory Corporation of America holds a potential value of $4.6 million to provide COVID-19 testing services for FDA employees and contractors. Two firm fixed price delivery orders have been awarded against the contract to date, for $149,949.15 and $20,069.53 respectively, with periods of performance through July 2023 and March 2022. Place of performance will be...
The Centers for Disease Control and Prevention (CDC) awarded a Blanket Purchase Agreement (BPA) contract to Abbott Molecular Inc., a subsidiary of Abbott Laboratories, to provide reagents, consumables, and other diagnostic supplies in support of the agency's laboratory testing and disease monitoring capabilities. The $1.25 million single-award contract, issued against the General Services Administration's (GSA) In Vitro Diagnostics, Reagents, and Test (FSS-65-VII) Schedule, has an ultimate...